Literature DB >> 16364488

Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

Claire Z Larter1, Geoffrey C Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16364488     DOI： 10.1016/j.jhep.2005.11.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  38 in total

Review 1.  Nonalcoholic fatty liver disease and HIV infection.

Authors:  Raphael B Merriman
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

Review 2.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 3.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.

Authors:  Weibin Qian; Junichi Hasegawa; Satoshi Tsuno; Yusuke Endo; Akiko Matsuda; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

5.  Pentoxifylline: not just for alcoholic hepatitis anymore?

Authors:  Roman E Perri; Vijay H Shah
Journal:  Hepatol Int       Date:  2008-04-08       Impact factor: 6.047

Review 6.  Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.

Authors:  Long-Xin Qiu; Tong Chen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

7.  Effect of Probiotic Soy Milk on Serum Levels of Adiponectin, Inflammatory Mediators, Lipid Profile, and Fasting Blood Glucose Among Patients with Type II Diabetes Mellitus.

Authors:  Sadegh Feizollahzadeh; Reza Ghiasvand; Abbas Rezaei; Hossein Khanahmad; Akram Sadeghi; Mitra Hariri
Journal:  Probiotics Antimicrob Proteins       Date:  2017-03       Impact factor: 4.609

8.  The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.

Authors:  Masahiko Koda; Manri Kawakami; Yoshikazu Murawaki; Miho Senda
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

9.  Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).

Authors:  José Tadeu Stefano; Claudia Pinto Marques Souza de Oliveira; Maria Lúcia Corrêa-Giannella; Vicência Mara Rodrigues de Lima; Sandra Valéria de Sá; Ellen Pierre de Oliveira; Evandro Sobroza de Mello; Daniel Giannella-Neto; Venâncio Avancini Ferreira Alves; Flair José Carrilho
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

10.  IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.

Authors:  Emmanuel Mas; Marie Danjoux; Virginie Garcia; Stéphane Carpentier; Bruno Ségui; Thierry Levade
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.